QUADRANT CAPITAL GROUP LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$20,175
-0.0%
535
+0.6%
0.00%0.0%
Q2 2023$20,179
-32.2%
532
-56.5%
0.00%
-33.3%
Q1 2023$29,768
+97.9%
1,224
+136.3%
0.00%
+50.0%
Q4 2022$15,043
-60.4%
518
-59.4%
0.00%
-60.0%
Q3 2022$38,000
+111.1%
1,275
+154.5%
0.01%
+150.0%
Q2 2022$18,000
+260.0%
501
+368.2%
0.00%
+100.0%
Q1 2022$5,000
-84.4%
107
-83.0%
0.00%
-75.0%
Q4 2021$32,000
+255.6%
629
+362.5%
0.00%
+300.0%
Q3 2021$9,000
+28.6%
136
+38.8%
0.00%0.0%
Q2 2021$7,0000.0%980.0%0.00%0.0%
Q1 2021$7,0000.0%980.0%0.00%0.0%
Q4 2020$7,000
+133.3%
98
+63.3%
0.00%0.0%
Q3 2020$3,000
-25.0%
60
+7.1%
0.00%0.0%
Q3 2018$4,000
-20.0%
560.0%0.00%
-50.0%
Q2 2018$5,000
+25.0%
560.0%0.00%
+100.0%
Q1 2018$4,000
-76.5%
56
-71.0%
0.00%
-85.7%
Q4 2017$17,000
-10.5%
1930.0%0.01%
-12.5%
Q3 2017$19,000
-58.7%
193
-57.9%
0.01%
-60.0%
Q2 2017$46,000
+24.3%
458
+29.7%
0.02%
+25.0%
Q1 2017$37,000
+131.2%
353
+94.0%
0.02%
+100.0%
Q4 2016$16,000
+700.0%
182
+628.0%
0.01%
+700.0%
Q3 2016$2,0000.0%25
-21.9%
0.00%0.0%
Q2 2016$2,000
+100.0%
32
+128.6%
0.00%0.0%
Q1 2016$1,0000.0%14
+27.3%
0.00%0.0%
Q4 2015$1,000
-87.5%
11
-82.0%
0.00%
-83.3%
Q3 2015$8,0000.0%610.0%0.01%
+20.0%
Q2 2015$8,000610.01%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders